Videos

Thanks to advanced proton therapy, doctors can precisely start irradiating brain tumours. Unfortunately, they do not yet dare to use this technique on tumours in the belly. Why? Because it's a bit like playing darts with a blindfold, while you have to hit a moving target, as Sophie Heymans explains in this video. She tells you about the technique she is working on to help doctors face this challenge.

Up to 25% of the cells present in lung cancer tumours are currently ignored. As such, we don't know what the role of these so-called B cells is. "It is crucial to figure that out because we cannot efficiently fight something we do not fully understand," says Pauline Bardet (VUB - VIB - FWO).

In her PhD, she wants to get to the bottom of those B cells and thus find out whether those cells are "good guys" or "bad guys".

When removing a kidney tumor, a surgeon has just 20 minutes to do the job. During the operation, the surgeon has to cut off the blood supply to the kidney to avoid a true blood bath. But if the kidney is without blood for too long, too much of it will die off, causing the kidney to malfunction. Using mathematical models, Saar Vermijs aims to help surgeons in their race against the clock...

Today, we can treat cancer better than ever. Yet some cancer types remain very difficult to fight. Such is the case of glioblastoma, a highly aggressive brain cancer in which only 7 in 100 patients are still alive five years after diagnosis. Hoping to help glioblastoma get small, Joke Deschildre doctored a sophisticated strategy to attack cancer cells.

Over the past five years, solid progress has been made in the fight against cancer, but unfortunately, that does not apply to pancreatic cancer. So what makes this cancer so hard to beat? Olaya Lara (VUB) explains this by comparing it to a football match. She also tells you what tactics she figures out to sideline xCT, the Lionel Messi in the pancreatic cancer team. 

Cancer is a sneaky disease. For instance, cancer cells sometimes manage to disguise themselves, outrunning our immune system. Gils Roex (UAntwerpen - FWO) explains how equipping our white blood cells with a cleverly designed CAR could well help win the race against blood cancer. Want to know more? Fasten your seatbelts & watch the video 🏎

Why do cancer patients relapse despite receiving treatment? This is often due to dormant cancer cells. These cells lie dormant in the body and manage to escape treatment, for example, chemotherapy. Can substances from camel and llama blood provide a breakthrough?

Did you know that cancer cells are not so different from our healthy cells? This makes it difficult for T-cells, important immune cells in our body, to recognise and fight cancer cells. Cancer researcher Heleen Hanssens (VUB-FWO) wants to give T-cells a helping hand by equipping them with more sensitive receptors, or antennae, that are pre-programmed to unmask cancer cells. In the lab, she is looking for the perfect form for these CAR antennae, so that they become more stable and better at detecting cancer cells. 

Radiation can save the lives of people with head and neck cancer. Unfortunately, many patients develop swallowing disorders as a result of the treatment, which makes it impossible for them to eat solid food. Leen Van den Steen (UAntwerpen - UZA) wants to help them. How? With tongue strength training.

"Each person is unique. So why do we still treat every woman with ovarian cancer the same way?" Liselore Loverix (KU Leuven - FWO) examines patient by patient and looks for errors in the DNA of their tumour cells. In this way, before treatment starts, she identifies which patient would benefit from a new, targeted therapy based on cancer drugs.

In Belgium, every year more than 25,000 people return to work after cancer treatment. Yet there are many employers who do not know how to react in such a situation. Elise Pattyn (Arteveldehogeschool) and her colleagues are working on tools to make the return to work smoother.

As if developing a cancer drug is not difficult enough, you still have to successfully get that medicine to the tumor. Tim Bomberna (Ghent University) explains how computer simulations show us the way.